Yatırımcı.AI

BISTTRY10:00Live

Türk İlaç ve Serum Sanayi A.Ş.

Türk İlaç ve Serum Sanayi A.Ş.TRILC

Watchlist MarketChemicals, Petroleum, Rubber and Plastics
0.910.01 (1.11%)
Volume
TRY 206.8K
Day range
0.91 – 0.91
Previous close
0.90
Market cap
TRY 943.7M

TRILC Ratio Analysis: P/E, P/B, EV/EBITDA

35 key ratios for Türk İlaç ve Serum Sanayi A.Ş. (TRILC) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E—
P/B0.48
EV/EBITDA3.68
Dividend yield—
Beta—
Earnings per share−0.1 TL
Book value per share1.9 TL
EBITDA262.7M TL
Net profit207.6M TL
Operating profit322.9M TL
Operating profit before finance costs272.8M TL
Net working capital−41.7M TL
Gross margin25.29%
Operating margin23.26%
Net margin14.95%
Return on assets−1.24%
Return on equity−4.59%
Current ratio0.99
Quick ratio0.70
Cash ratio—
Leverage ratio76.53
Debt to equity3.26
Debt to assets0.77
Fixed assets to equity1.47
Short-term debt share0.45
Interest coverage—
Receivables turnover0.14
Days sales outstanding2,607
Inventory turnover0.63
Days inventory outstanding579
Payables turnover0.88
Days payables outstanding415
Working capital turnover−33.29
Equity turnover0.70
Asset turnover0.16

Frequently asked questions

TRILC has a P/E ratio of —, a P/B ratio of 0.48 and an EV/EBITDA of 3.68.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.